Skip to content

MEDICAL INNOVATION HOLDINGS, INC.: 10-K filed 2012-08-14

What MEDICAL INNOVATION HOLDINGS, INC. reported in its annual report filed 2012-08-14 (fiscal FY 2012): 35 published measures, 72 facts as tagged in accession 0001072588-12-000105.

This filing

Form
10-K (annual report)
Filed
2012-08-14
Fiscal period
fiscal FY 2012
Accession
0001072588-12-000105 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All MEDICAL INNOVATION HOLDINGS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-04-30546,160USD
At 2011-04-30580,285USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-04-302,536,363USD
At 2011-04-302,825,258USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-04-30-1,990,203USD
At 2011-04-30-2,244,973USD
At 2010-04-30-1,684,326USD
At 2009-04-30-2,268,696USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2011-05-01 to 2012-04-30-1,246,686USD366
2009-05-01 to 2010-04-30-742,070USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-05-01 to 2012-04-30-415,545USD366
2010-05-01 to 2011-04-3014,295USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2011-05-01 to 2012-04-30107,034USD366
2010-05-01 to 2011-04-3033,158USD365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2011-05-01 to 2012-04-30419,397USD366
2010-05-01 to 2011-04-301,542,436USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2011-05-01 to 2012-04-30505,226USD366
2010-05-01 to 2011-04-30-71,007USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2011-05-01 to 2012-04-30-107,034USD366
2010-05-01 to 2011-04-30-33,158USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2012-04-30-7,256,062USD
At 2011-04-30-6,009,376USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2011-05-01 to 2012-04-3052,803,323shares366
2010-05-01 to 2011-04-3051,025,792shares365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2011-05-01 to 2012-04-3052,803,323shares366
2010-05-01 to 2011-04-3051,025,792shares365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2011-05-01 to 2012-04-30-0.02USD/shares366
2010-05-01 to 2011-04-30-0.01USD/shares365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2011-05-01 to 2012-04-30-0.02USD/shares366
2010-05-01 to 2011-04-30-0.01USD/shares365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-04-30312,126USD
At 2011-04-30425,941USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2011-05-01 to 2012-04-30-1,076,396USD366
2010-05-01 to 2011-04-30-528,414USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-04-30224,566USD
At 2011-04-30122,883USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2011-05-01 to 2012-04-30187,454USD366
2010-05-01 to 2011-04-3069,654USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-04-302,536,363USD
At 2011-04-302,825,258USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2012-04-30684,678USD
At 2011-04-30759,866USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2012-04-30224,566USD
At 2011-04-3099,640USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2011-05-01 to 2012-04-3076,658USD366
2010-05-01 to 2011-04-30512,531USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-04-3055,890,117shares
At 2011-04-3051,110,497shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2012-04-304,880,270USD
At 2011-04-303,519,292USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2012-04-30753,332USD
At 2011-04-30848,213USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2012-04-30441,206USD
At 2011-04-30422,272USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2012-04-30458,947USD
At 2011-04-30295,994USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2011-05-01 to 2012-04-30-1,246,686USD366
2010-05-01 to 2011-04-30-566,022USD365

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2011-05-01 to 2012-04-30-1,246,686USD366
2010-05-01 to 2011-04-30-566,022USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2011-05-01 to 2012-04-301,089,619USD366
2010-05-01 to 2011-04-30664,929USD365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2011-05-01 to 2012-04-30119,892USD366
2010-05-01 to 2011-04-30159,273USD365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2011-05-01 to 2012-04-3017,164USD366
2010-05-01 to 2011-04-3032,046USD365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2011-05-01 to 2012-04-30-5,890USD366
2010-05-01 to 2011-04-30-56,394USD365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2011-05-01 to 2012-04-30124,927USD366
2010-05-01 to 2011-04-30-65,012USD365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2011-05-01 to 2012-04-3093,218USD366
2010-05-01 to 2011-04-30121,842USD365

Inspect the source

Entity
MEDICAL INNOVATION HOLDINGS, INC. / CIK 0001093248
Captured
SEC response SHA-256
c30aa23f398e23911e2680b158b007e8993aac602f1ddc874d738bbf7c09e857

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001093248.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))